Rocklatan is a Ophthalmic; Topical Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Aerie Pharmaceuticals, Inc.. The primary component is Netarsudil Mesylate; Latanoprost.
Product ID | 70727-529_011e405d-e9cd-4e7a-b145-270d2baf0074 |
NDC | 70727-529 |
Product Type | Human Prescription Drug |
Proprietary Name | Rocklatan |
Generic Name | Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005% |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC; TOPICAL |
Marketing Start Date | 2019-03-12 |
Marketing Category | NDA / NDA |
Application Number | NDA208259 |
Labeler Name | Aerie Pharmaceuticals, Inc. |
Substance Name | NETARSUDIL MESYLATE; LATANOPROST |
Active Ingredient Strength | 0 mg/mL; mg/mL |
Pharm Classes | Rho Kinase Inhibitor [EPC],Rho Kinase Inhibitors [MoA],Prostaglandin Analog [EPC],Prostaglandins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-03-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208259 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-03-12 |
Marketing Category | NDA |
Application Number | NDA208259 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-03-12 |
Ingredient | Strength |
---|---|
NETARSUDIL MESYLATE | .2 mg/mL |
SPL SET ID: | b1d71f41-be06-4a08-94d4-e352198f09c2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ROCKLATAN 88293353 not registered Live/Pending |
Aerie Pharmaceuticals, Inc. 2019-02-07 |
ROCKLATAN 88293345 not registered Live/Pending |
Aerie Pharmaceuticals, Inc. 2019-02-07 |
ROCKLATAN 86918084 5715857 Live/Registered |
Aerie Pharmaceuticals, Inc. 2016-02-24 |